CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 10.75
+0.25 (2.38%)
Jul 6, 2026, 12:43 PM GMT
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 5.83 million as of July 6, 2026. Its market cap has decreased by -17.02% in one year.
Market Cap
5.83M
Enterprise Value
4.70M
Revenue
231.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
10.75
Market Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 5.83M, a decrease of -79.35%. That is a compound annual growth rate of -7.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 5.83M | 12.69% |
| Dec 31, 2025 | 5.17M | 43.93% |
| Dec 31, 2024 | 3.59M | -74.19% |
| Dec 30, 2022 | 13.93M | -40.80% |
| Dec 31, 2021 | 23.53M | 6.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fusion Antibodies | 15.00M |
| Palatin Technologies | 14.43M |
| Genflow Biosciences | 11.61M |
| Cizzle Biotechnology Holdings | 10.62M |
| OptiBiotix Health | 6.66M |
| Thalia Therapeutics | 5.41M |
| Oxford BioDynamics | 4.72M |
| Nuformix | 4.70M |